IRIS
MORI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.235
EU - Europa 6.821
AS - Asia 4.747
SA - Sud America 1.307
AF - Africa 247
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 22.378
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.117
RU - Federazione Russa 1.647
SG - Singapore 1.609
CN - Cina 1.239
GB - Regno Unito 1.170
BR - Brasile 1.071
IE - Irlanda 1.012
IT - Italia 1.002
VN - Vietnam 687
FR - Francia 492
HK - Hong Kong 485
SE - Svezia 345
DE - Germania 336
UA - Ucraina 335
KR - Corea 183
FI - Finlandia 176
IN - India 137
AR - Argentina 111
ZA - Sudafrica 104
BD - Bangladesh 61
ES - Italia 54
TR - Turchia 54
CA - Canada 53
NL - Olanda 41
IQ - Iraq 40
MX - Messico 40
CZ - Repubblica Ceca 39
PL - Polonia 38
ID - Indonesia 37
EC - Ecuador 34
JP - Giappone 34
PK - Pakistan 32
AT - Austria 31
CI - Costa d'Avorio 26
KE - Kenya 26
CO - Colombia 24
SA - Arabia Saudita 23
CL - Cile 20
NG - Nigeria 20
BE - Belgio 19
MA - Marocco 18
EG - Egitto 16
VE - Venezuela 16
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
TN - Tunisia 14
DZ - Algeria 12
IR - Iran 12
JO - Giordania 12
PY - Paraguay 10
UZ - Uzbekistan 10
AU - Australia 9
AZ - Azerbaigian 9
MY - Malesia 9
PE - Perù 9
GR - Grecia 8
NP - Nepal 8
UY - Uruguay 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
EU - Europa 7
PT - Portogallo 7
IL - Israele 6
KZ - Kazakistan 6
AL - Albania 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
BY - Bielorussia 4
CY - Cipro 4
HU - Ungheria 4
LB - Libano 4
LT - Lituania 4
PA - Panama 4
RO - Romania 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
HN - Honduras 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
QA - Qatar 3
SI - Slovenia 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 22.354
Salva come PNG Salva come JPEG
Città #
Dallas 1.604
Southend 1.012
Dublin 1.006
Fairfield 940
Singapore 803
Ashburn 710
Woodbridge 476
Hong Kong 464
Moscow 456
Seattle 415
Beijing 386
Chandler 353
Wilmington 350
Houston 341
Cambridge 328
Siena 309
Santa Clara 260
San Jose 252
Hefei 224
Jacksonville 222
Ann Arbor 207
Ho Chi Minh City 205
Menlo Park 201
Princeton 200
Seoul 182
Hanoi 154
Lauterbourg 149
Los Angeles 149
Council Bluffs 142
New York 123
The Dalles 123
San Mateo 97
Milan 92
Munich 91
Helsinki 87
Rome 86
São Paulo 86
Johannesburg 76
San Diego 67
Nanjing 65
Dong Ket 62
Boardman 61
Buffalo 60
Redwood City 60
Florence 46
Bengaluru 42
Redondo Beach 42
Lappeenranta 41
Fremont 39
Shanghai 39
London 36
Rio de Janeiro 34
Chicago 33
Nuremberg 29
Brno 28
Phoenix 28
Tokyo 28
Haiphong 27
Abidjan 26
Frankfurt am Main 26
Columbus 24
Izmir 24
Nanchang 23
Düsseldorf 22
Orem 22
Baghdad 21
Chennai 21
Da Nang 21
Salamanca 21
Shenyang 20
Warsaw 20
Belo Horizonte 19
Brussels 19
San Francisco 19
Brasília 18
Hải Dương 18
Jinan 18
Montreal 18
Norwalk 18
Abuja 17
Brooklyn 16
Curitiba 16
Toronto 16
Dearborn 15
Guangzhou 15
Atlanta 14
Boston 14
Buenos Aires 14
Turku 14
Denver 13
Dhaka 13
Mumbai 13
Málaga 13
Salvador 13
Sofia 13
Amsterdam 12
Bắc Ninh 12
Campinas 12
Guayaquil 12
Nairobi 12
Totale 14.955
Salva come PNG Salva come JPEG
Nome #
Biological Evaluation and Computational Modelling Studies on N-acyl Hydrazone and 2,5-Disubstituted 1,3,4-Oxadiazole Derivatives as Non-toxic Antimicrobial Agents 501
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors 399
Chemically stable inhibitors of 14-3-3 protein–protein interactions derived from BV02 324
Structure-Based Identification of HIV-1 Nucleocapsid Protein Inhibitors Active against Wild-Type and Drug-Resistant HIV-1 Strains 295
Molecular insights to the bioactive form of BV02, a reference inhibitor of 14-3-3σ protein-protein interactions 288
Structure, function, involvement in diseases and targeting of 14-3-3 proteins: An Update 284
(Thia)calixarenephosphonic Acids as Potent Inhibitors of the Nucleic Acid Chaperone Activity of the HIV-1 Nucleocapsid Protein with a New Binding Mode and Multitarget Antiviral Activity 284
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors 275
Differentially activated Src kinase in chemo-naive human primary osteosarcoma cells and effects of a Src kinase inhibitor 265
In Memory of Maurizio Botta: His Contribution to the Development of Computer-Aided Drug Design 263
Discovery of in vitro antitubercular agents through in silico ligand-based approaches 262
Potent and selective carboxylic acid inhibitors of tumor-associated carbonic anhydrases IX and XII 259
5,6-Dihydroxypyrimidine Scaffold to Target HIV-1 Nucleocapsid Protein 258
Tautomers of a Fluorescent G Surrogate and Their Distinct Photophysics Provide Additional Information Channels 257
Discovery of 14-3-3 Protein-Protein Interaction Inhibitors that Sensitize Multidrug-Resistant Cancer Cells to Doxorubicin and the Akt Inhibitor GSK690693 251
Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3s case 250
Identification of Phosphate-Containing Compounds as New Inhibitors of 14-3-3/c-Abl Protein-Protein Interaction 250
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 237
A selective competitive inhibitor of aldehyde dehydrogenase 1A3 hinders cancer cell growth, invasiveness and stemness in vitro 232
Hit Recycling: Discovery of a Potent Carbonic Anhydrase Inhibitor by in Silico Target Fishing 227
Inhibition of melanoma cell migration and invasion targeting the hypoxic tumor associated caxii 226
Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein 224
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors 220
Small molecules modulation of 14-3-3 protein–protein interactions 212
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor 211
Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein 210
Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1 208
A Class of Potent Inhibitors of the HIV-1 Nucleocapsid Protein Based on Aminopyrrolic Scaffolds 204
Naturally occurring Diels-Alder-type adducts from Morus nigra as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase B 195
Mycobacterial carbonic anhydrase inhibition with phenolic acids and esters: kinetic and computational investigations 193
Multitarget hedgehog pathway inhibitors and uses thereof 190
Structure Prediction and Validation of the ERK8 Kinase Domain 186
Free energy profile and kinetics studies of paclitaxel internalization from the outer to the inner wall of microtubules 179
Hedgehog Pathway Inhibition by Novel Small Molecules Impairs Melanoma Cell Migration and Invasion under Hypoxia 178
Use of virtual screening for discovering antiretroviral compounds interacting with the HIV-1 nucleocapsid protein 176
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma 176
Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulators 175
Probing the Pore Drug Binding Site ofMicrotubules with Fluorescent Taxanes:Evidence of Two Binding Poses 175
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines 175
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone 171
Predicting the Binding Mode of Known NCp7 Inhibitors To Facilitate the Design of Novel Modulators 170
Targeting Protein-Protein and Protein-Nucleic Acid Interactions for Anti-HIV Therapy 168
Molecular Dynamics and DFT Study on HIV-1 Nucleocapsid Protein-7 in Complex with Viral Genome 164
A smo/gli multitarget hedgehog pathway inhibitor impairs tumor growth 164
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge 163
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors 162
Nucleocapsid protein: A desirable target for future therapies against HIV-1 157
Nigritanine as a new potential antimicrobial alkaloid for the treatment of staphylococcus aureus-induced infections 157
Experimental and Computational Druggability Exploration of the 14-3-3ζ/SOS1pS1161PPI Interface 157
Natural products inspired modulators of cancer stem cells-specific signaling pathways notch and hedgehog 156
A Molecular Tool Targeting the Base-Flipping Activity of Human UHRF1 156
A Highly Soluble Matrix Metalloproteinase-9 Inhibitor for Potential Treatment of Dry Eye Syndrome 156
Targeting GLI factors to inhibit the Hedgehog pathway 154
Discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (PtpB) inhibitors from natural products 153
Alvaxanthone, a thymidylate synthase inhibitor with nematocidal and tumoricidal activities 143
14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban 142
A chalcone derivative binds a putative allosteric site of YopH: Inhibition of a virulence factor of Yersinia 141
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: synthesis and biological evaluation for chronic myeloid leukemia treatment 141
Functional and structural characterization of 2-amino-4-phenylthiazole inhibitors of the HIV-1 nucleocapsid protein with antiviral activity 140
Oregonin from Alnus incana bark affects DNA methyltransferases expression and mitochondrial DNA copies in mouse embryonic fibroblasts 140
A deadly spillover: SARS-CoV-2 outbreak 138
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 137
Statins interfere with the attachment of S. cerevisiae mtDNA to the inner mitochondrial membrane 135
Novel sulfamide-containing compounds as selective carbonic anhydrase i inhibitors 134
Current trends in Hedgehog signaling pathway inhibition by small molecules 134
INHIBITORS OF ANTIBIOTIC RESISTANCE MEDIATED BY ARN T 134
Chalcones and Chalcone-mimetic Derivatives as Notch Inhibitors in a Model of T-cell Acute Lymphoblastic Leukemia 132
Thienoguanosine, a unique non-perturbing reporter for investigating rotational dynamics of DNA duplexes and their complexes with proteins 131
Histone demethylating agents as potential S-adenosyl-l-methionine-competitors 131
P300/CBP-associated factor regulates transcription and function of isocitrate dehydrogenase 2 during muscle differentiation 129
Conformational insights into the C-terminal mutations of human rhodopsin in retinitis pigmentosa 129
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells 129
Selective targeting of cancer-related G-Quadruplex structures by the natural compound dicentrine 126
Targeting the nucleocapsid protein of HIV-1 (NCp7) with nucleobase flexibility 126
Excited-State Dynamics of Thienoguanosine, an Isomorphic Highly Fluorescent Analogue of Guanosine 126
Yeast as a tool to select inhibitors of the cullin deneddylating enzyme Csn5 126
Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold 126
What makes thienoguanosine an outstanding fluorescent DNA probe? 124
Natural flavonoid derivatives have pan-Coronavirus antiviral activity 122
Synthesis of distal and proximal fleximer base analogues and evaluation in the nucleocapsid protein of HIV-1 122
Synthetic thiosemicarbazones as a new class of Mycobacterium tuberculosis protein tyrosine phosphatase A inhibitors 121
Natural products as an important source in drug discovery 121
Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells 120
Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action 120
Imidazo[1,2-a]pyridine derivatives as aldehyde dehydrogenase inhibitors: novel chemotypes to target glioblastoma stem cells 118
Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein 118
Hedgehog signaling pathway inhibitors: an updated patent review (2015–present) 117
Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia 116
Antimalarial drugs: what's new in the patents? 114
null 114
One hundred faces of cyclopamine 114
Molecular Dynamics Simulations and Structural Analysis of Giardia Duodenalis 14-3-3 Protein-Protein Interactions 113
In Memory of Maurizio Botta: His Vision of Medicinal Chemistry 112
Dual SMO/BRAF inhibition by flavonolignans from Silybum marianum† 112
Ent-Beyerane Diterpenes as a Key Platform for the Development of ArnT-Mediated Colistin Resistance Inhibitors 112
Novel insights on human carbonic anhydrase inhibitors based on coumalic acid: design, synthesis, molecular modeling investigation, and biological studies 109
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 108
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold 108
Synthesis of flexible purine analog inhibitors of NCp7 107
Acipimox inhibits human carbonic anhydrases 107
Totale 17.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021577 0 0 0 0 0 0 0 0 0 263 86 228
2021/20221.469 78 183 148 30 51 89 75 53 119 154 176 313
2022/20231.669 144 172 249 237 95 351 33 119 142 37 44 46
2023/20241.725 48 32 130 139 39 395 518 60 13 38 51 262
2024/20253.726 118 262 264 280 279 185 148 162 336 272 382 1.038
2025/20268.500 671 1.304 1.588 1.258 1.480 271 860 270 350 448 0 0
Totale 22.940